The culmination of research efforts reveals a compelling narrative wherein the expression patterns of claudins, with particular emphasis on CLDN5, CLDN11, and CLDN18, emerge as integral players intricately woven into the fabric of immune modulation, cancer-related pathways, malignant phenotypes, and diagnostic precision within the context of COAD. This evidence concerns the gene CLDN5 and cancer.